Epoch Biodesign
Develops biological recycling processes and commercial plants to break down and recover nylon 6.6 waste for circular material supply chains.
Overview
Epoch Biodesign develops biological recycling processes and commercial biorecycling plants to process nylon 6.6 waste, aiming to recover materials for circular supply chains. The company is focused on industrial-scale solutions within the polymer recycling market and positions its facilities as alternatives to mechanical or petrochemical routes for end-of-life nylon 6.6. Based in London, Epoch raised £9M from Extantia and Kompas VC in an undisclosed round announced 25 March 2026 to fund its largest nylon 6.6 biorecycling plant. The financing brings total disclosed capital to $13M across one round and is intended to support scale-up and plant deployment.
Funding History
London’s Epoch Biodesign raises £9M from Extantia and Kompas VC for its largest nylon 6.6 biorecycling plant
Frequently Asked Questions
- How much has Epoch Biodesign raised in total?
- Epoch Biodesign has raised a total of $13M across 1 funding round.
- Who are Epoch Biodesign's investors?
- Epoch Biodesign's investors include Undisclosed.
- What does Epoch Biodesign do?
- Epoch Biodesign develops biological recycling processes and commercial biorecycling plants to process nylon 6.6 waste, aiming to recover materials for circular supply chains. The company is focused on industrial-scale solutions within the polymer recycling market and positions its facilities as alternatives to mechanical or petrochemical routes for end-of-life nylon 6.6. Based in London, Epoch raised £9M from Extantia and Kompas VC in an undisclosed round announced 25 March 2026 to fund its largest nylon 6.6 biorecycling plant. The financing brings total disclosed capital to $13M across one round and is intended to support scale-up and plant deployment.
- Where is Epoch Biodesign headquartered?
- Epoch Biodesign is headquartered in London, UK.
Investors
Related Insights
A comprehensive analysis of Hebbia's funding history, investors, competitive position, and growth trajectory in the Enterprise AI space.
An in-depth analysis of Lux Capital's AI investment portfolio, strategy, co-investors, and sector focus across 4 tracked deals.
A comprehensive analysis of Mind Robotics's funding history, investors, competitive position, and growth trajectory in the AI space.